Emergent BioSolutions (NYSE:EBS) layoffs are in the news as the life sciences company prepares to cut jobs and close down certain facilities. According to a release from Emergent BioSolutions, these layoffs will affect 300 of its employees. The company also says that it will be closing 85 open positions that are currently vacant. The job cuts will also see Emergent BioSolutions close down two of its locations. That includes its Baltimore- Bayview Drug Substance manufacturing facility and Rockville, Maryland ...